Company / Depreciation & Amortization
IQVIA Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.1B
FY2025
5-year range
$1.1B / $1.3B
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#11 of 142
Health Care
What the data says
Among 142 Health Care companies, IQVIA is in the bottom 8% for depreciation & amortization. Depreciation & Amortization returned to growth in FY2025 after 2 years of decline, reaching $1.1B.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +0.1%. Top quartile in the Health Care sector.
Remained stable around $1.1B over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -3.9%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Sector benchmark
+229.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.1%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 2.7% year-over-year.
- Ranks #11 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +2.7% |
| FY2024 | $1.1B | -1.0% |
| FY2023 | $1.1B | -12.6% |
| FY2022 | $1.3B | +7.1% |
| FY2021 | $1.2B | +5.3% |
| FY2020 | $1.1B | +12.9% |
| FY2019 | $1.0B | +249.8% |
| FY2018 | $289.0M | -71.4% |
| FY2017 | $1.0B | +249.8% |
| FY2016 | $289.0M | +125.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026